CLINICAL_TRIALS trial_result · 2026-07-10

Clinical Trial Results: Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD [Phase 3]

Phase 3 randomized, double-blind trial of REL-1017 as adjunctive treatment for major depressive disorder was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Levomecor Inc. | Conditions: Major Depressive Disorder, Depression | Phase 3 | Status: TERMINATED | Results posted: 2026-07-10